Visit 1 Screening (0 months) | Visit 2 (3 months) | Visit 3 (6 months) | Visit 4 (9 months) | Visit 5 (12 months) | |
---|---|---|---|---|---|
Recruitment following the selection criteria | X | ||||
Informed consent | X | ||||
Initial collection clinical information and sociodemographic data | X | ||||
BP control | X | X | X | X | X |
Lipid profile control | X | X | X | ||
Counting of drug packages | X | X | X | X | |
Morisky-Green test | X | X | X | X | X |
Data collection for errors and adverse effects | X | X | X | X | |
Collection of followed-up clinical variables | X | X | X | X |